You arent selling a vitamin, you are selling a permissible treat that happens to solve a problem the user is currently fighting
Further research is needed to establish the exact chemical nature of available compounded GLP-1 products
Frustaci A, Neri M, Cesario A, et al
Additionally, GLP-1 RAs with established CV benefitsspecifically liraglutide, subcutaneous semaglutide, dulaglutide, and efpeglenatideare recommended for patients with T2DM and ASCVD to reduce CV events, regardless of baseline or target HbA1c levels or concurrent glucose-lowering therapy (Class I, LoE A)
Portion control: Pay attention to portion sizes to help manage calorie intake and weight
Therefore, therapeutic principles acting via different receptors and postreceptor pathways seem attractive in view of potentially additive or synergistic effects